Epidermal growth factor (EGF) bound specifically to the human hepatoma cell line PLC/PRF/5. Treatment of these cells with nanomolar concentrations of EGF for 4-6 hr resulted in a 2-to 6-fold increase in ornithine decarboxylase (L-or-nithine carboxy-lyase, EC 4.1.1.17) activity. 12-0-Tetradecanoylphorbol 13-acetate also produced an increase in enzyme activity in these cells and exhibited an additive effect with EGF Epidermal growth factor (EGF) influences a number ofcellular processes such as nutrient transport; protein, RNA, and DNA synthesis; and cell multiplication in many normal and abnormal cell types (1). One enzyme whose cellular level is increased by EGF treatment is ornithine decarboxylase (OrnDCase; L-ornithine carboxy-lyase, EC 4.1.1.17), which catalyzes the ratelimiting step in polyamine biosynthesis (2). This enzyme is of special interest because polyamines have been implicated in the regulation ofcell growth (3,4). EGF elevated OrnDCase levels in the testes, kidney, liver, stomach, and duodenum of mice injected with the growth factor (5, 6). In vitro, EGF increased OrnDCase levels in mouse and human skin fibroblasts (7), porcine granulosa cells (8), and normal rat kidney cells (9).Recently, we demonstrated the specific interaction of EGF with cell surface receptors on normal adult rat liver cells in primary culture (10). These cells are maintained as nondividing cultures. To assess the EGF effects on a dividing population of liver cells, we have used the human hepatoma cell line PLC/ PRF/5. This cell line was established in 1976 and was found to produce hepatitis B surface antigen (11,12). DiSorbo et al. (13) demonstrated the presence ofthe hepatic glucocorticoid receptor and the ability of glucocorticoids to induce tyrosine aminotransferase activity in these cells. As they do not synthesize albumin or alpha fetoprotein but do synthesize several other plasma proteins (14), it appears that only partially differentiated liver cell function is present in these cells. Elucidation of the hormonal factors that may be involved in the growth of tumorderived cells is of key importance in understanding the conditions that initiate and sustain malignant growth.We have examined the binding of EGF to the PLC/PRF/ 5 cells and the effect of EGF treatment on their OrnDCase activity level. The human hepatoma cells were found to have specific high-affinity binding sites for EGF and to exhibit increased OrnDCase activity after exposure to EGF for several hours.Thus, EGF may be one humoral factor involved in the regulation of liver cell growth. The tumor promotor, 12-0-tetradecanoylphorbol 13-acetate (TPA), had an effect similar to EGF on OrnDCase activity in this cell line.
MATERIALS AND METHODSCell Cultures. The human hepatoma cell line PLC/PRF/5 was obtained from the Wistar Institute (Philadelphia, PA). The cells were grown in an air incubator using Eagle's minimal essential medium-alpha growth medium (GIBCO)/4 mM glutamine/7% fetal bovine serum (North American Biologicals, Miami, FL)/50 mM N-2-hydroxyeth...